Plaque Psoriasis: Symptoms, Causes, and Treatment

Plaque psoriasis is the form most people picture when they hear the word "psoriasis" — and for good reason. It accounts for 80–90% of all psoriasis diagnoses, making it by far the most common type. Raised, thickened patches of skin covered with a characteristic silvery-white scale are its defining feature. But the experience of plaque psoriasis varies considerably — how many plaques, how large, where they appear, how intensely they itch, and how they respond to treatment are different for every person. This guide covers what plaque psoriasis is, what drives it, what triggers it, and what the full treatment pathway looks like.

What It Looks Like

Plaque psoriasis produces raised, inflamed patches of skin — called plaques — covered with a buildup of dead skin cells that forms a characteristic silvery-white scale. On lighter skin tones, the underlying skin is typically red. On darker skin tones, plaques often appear as thicker patches with a purple, grayish, or dark brown coloration rather than red, and the scale may be less visually prominent against the skin. Recognizing psoriasis across different skin tones is an important clinical point — the condition is underdiagnosed and undertreated in people with darker skin partly because the classic "red plaque" description does not match what they see.

Plaques range from small, isolated patches to large areas where multiple plaques have merged. They are usually well-defined — meaning there is a clear border between the affected and unaffected skin. The surface scale tends to be dry and can flake off in sheets. Underneath, the skin is often shiny, inflamed, and prone to bleeding when the scale is removed. Itch is one of the most commonly reported symptoms and can range from mild background itch to intense and sleep-disrupting.

Where Plaque Psoriasis Appears

Plaques can develop anywhere on the body, but certain locations are significantly more common than others. The elbows, knees, scalp, and lower back are the classic sites — these are the locations where psoriasis is most likely to appear first and where plaques tend to be most persistent.

What Causes Plaque Psoriasis

Plaque psoriasis is an autoimmune condition — the immune system malfunctions, causing T-cells to attack healthy skin cells rather than foreign invaders. This mistaken immune attack triggers the body to produce new skin cells at a dramatically accelerated rate. Normal skin cell turnover takes approximately 28–30 days. In plaque psoriasis, that cycle compresses to 3–4 days. The skin cells pile up on the surface faster than they can shed, forming the characteristic thickened plaques.

Genetics play a significant role — having a first-degree relative with psoriasis substantially increases your risk. But genetics alone do not determine who develops the condition. Environmental triggers activate the immune response in genetically predisposed people, which is why psoriasis often appears or worsens in response to identifiable events.

Common triggers

Treatment — The Full Pathway

Treatment for plaque psoriasis is stepped — starting with the least intensive effective option and moving toward more systemic approaches as severity increases. There is no single best treatment; what works well for one person may be ineffective for another, and treatment plans are frequently adjusted over time.

Mild plaque psoriasis — topical treatment

For mild disease — typically defined as affecting less than 3% of the body surface — topical treatments are the first line. Coal tar slows the abnormally rapid skin cell turnover and reduces inflammation; it is available over the counter and has been used to treat psoriasis for over a century with a well-established safety profile. Salicylic acid softens and removes the scale buildup, improving the absorption of any treatment applied afterward — it is the most clinically useful OTC ingredient for preparing the skin. Nopsor combines both in a two-step nighttime system: Shampoo and Body Wash with salicylic acid first, followed by the Deep Moisturizing Pomade with coal tar.

Prescription topical corticosteroids in varying strengths are the most commonly prescribed topical treatment for plaque psoriasis — they reduce inflammation rapidly but are not recommended for long-term continuous use due to the risk of skin thinning. Vitamin D analogues slow cell turnover and are often used in combination with or alternating with corticosteroids. Daily moisturization with a thick, fragrance-free emollient is recommended for everyone with psoriasis, regardless of severity — keeping the skin hydrated reduces itch, prevents fissuring, and extends the benefit of active treatments. Coal tar age warning: not recommended for children under 2.

Moderate plaque psoriasis — phototherapy

When psoriasis covers more than 3–10% of the body surface, or when topicals are not providing adequate control, phototherapy becomes the next option. Narrowband UVB therapy — delivered in a dermatology office or via home units — slows skin cell turnover through UV exposure and is effective for widespread plaque psoriasis. It requires regular sessions (typically 2–3 times per week) for several months but has a favorable long-term safety profile. PUVA (psoralen plus UVA) is less commonly used today but remains an option for specific presentations.

Moderate to severe plaque psoriasis — systemic and biologic treatment

When psoriasis affects more than 10% of the body surface, significantly impairs quality of life, or fails to respond to topicals and phototherapy, systemic treatment is appropriate. Traditional systemic options include methotrexate, cyclosporine, and acitretin — all effective but requiring monitoring for side effects with extended use.

Biologics represent the most targeted and generally most effective treatment tier for moderate to severe plaque psoriasis. They work by blocking specific immune proteins — TNF-alpha, IL-17, IL-23 — that drive the psoriatic immune response. TNF inhibitors (adalimumab, etanercept) were the first approved; IL-17 inhibitors (secukinumab, ixekizumab) and IL-23 inhibitors (guselkumab, risankizumab) have shown high rates of clear or almost-clear skin in clinical trials and are now widely used. JAK inhibitors offer an oral alternative for patients who prefer not to use injections.

Living with Plaque Psoriasis

Psoriasis is a lifelong condition — symptoms resolve and recur throughout a person's life. Treatment reduces the frequency and severity of flares but does not cure the underlying immune dysfunction. Most people develop a personal understanding of their triggers over time and can reduce flare frequency by managing them. Stress management, consistent treatment adherence, avoiding known medication triggers, limiting alcohol, and maintaining a healthy weight are all associated with better long-term disease control.

Psoriasis also carries a meaningful risk of associated conditions — psoriatic arthritis develops in up to 30% of people with psoriasis, and psoriasis is associated with increased cardiovascular risk, metabolic syndrome, and depression. Regular dermatology follow-up is recommended not just for skin management but for monitoring these risks.